Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Smoking Cessation 1Hematuria 1Carcinoma, Transitional Cell 1

Interventions

Gemcitabine 33Cisplatin 22pembrolizumab 21Magnetic Resonance Spectroscopy 18Specimen Handling 16durvalumab 12Mitomycin 10enfortumab vedotin 9avelumab 9Nivolumab 9Cystoscopy 9Fluorouracil 8Carboplatin 8Radiation 7Cystectomy 7Radiotherapy 6Immunoglobulin G 6Docetaxel 6Disulfides 6atezolizumab 5Transurethral Resection of Bladder 5Mitozytrex 5Biopsy 5tremelimumab 4sacituzumab govitecan 4erdafitinib 4dehydroftorafur 4Standard of Care 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Urinalysis × 90 days × Clear all
NCT05646485 2026-05-01

Bladder Cancer Screening Trial

University of Texas Southwestern Medical Center

Phase NA Recruiting
1,000 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡